While I'm glad the argument has passed, I actually think this coronavirus discussion is indeed vaguely relevant to MSB. It highlights an important point - how people can read the same medical news and come to different conclusions.
Being able to read and correctly interpret medical news is an important part of investing in a company like MSB. It's a confusing topic, more so for people who haven't studied or worked in the medical field. As MSB investors we've learnt the hard way about how hard it is to convey complicated medical news in a way the public understands (LVAD announcement, anyone?)
Ann: Mesoblast Submits Completed BLA for Ryoncil to US FDA, page-74
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |